Perinatale Zwangsstörungen

 

 Buy Article Permissions and Reprints

Zusammenfassung

Unter einer perinatalen Zwangsstörung versteht man die Erstmanifestation bzw. Exazerbation von Zwangssymptomen während einer Schwangerschaft und/oder post partum. Über die Häufigkeit von Zwangsstörungen in der allgemein für psychische Erkrankungen als vulnerabel geltenden perinatalen Phase gibt es kaum verlässliche Daten. Klinisch überwiegen bei der eher multifaktoriell bedingten perinatalen Zwangsstörung Zwangsgedanken und Zwangshandlungen, die im Zusammenhang mit der Sorge um das Wohl des Ungeborenen bzw. Neugeborenen stehen. Eine differenzialdiagnostische Abgrenzung gegenüber Schwangerschaftspsychosen und postpartalen Depressionen ist oft schwierig. Bei der Behandlung sollten nicht medikamentöse Strategien bevorzugt werden und der Einsatz der SSRIs sollte streng indiziert erfolgen. Insgesamt jedoch liegen zu perinatalen Zwangsstörungen kaum kontrollierte Untersuchungen vor und das Wissen über diese spezielle Patientengruppe ist eher als gering einzustufen. Ziel dieser Übersichtsarbeit ist es, die perinatale Zwangsstörung hinsichtlich Phänomenologie, Pathogenese, Differenzialdiagnostik und Therapiemaßnahmen näher darzustellen. Ein frühzeitiges Erkennen und Einleiten von Therapiemaßnahmen erscheint von großer Bedeutung für den Aufbau einer guten und längerfristig stabilen Mutter-Kind-Beziehung zu sein.

Abstract

A perinatal obsessive-compulsive disorder (OCD) is defined as an illness exhibiting first symptoms in the context of pregnancy and the postpartal period. There are no valid data up to date concerning the incidence of OCD, which might be of multifactorial origin, in this period in which females are highly vulnerable for psychiatric diseases. From a clinical point of view, obsessions and compulsions are mainly related to the well-being of the foetus or newborn baby. Differential diagnosis of perinatal OCD including pregnancy psychosis and post-partum depression is often difficult. Concerning treatment, non-pharmacological approaches should be preferred. Administration of SSRIs should be strongly restricted. However, there are no controlled therapy studies in patients with perinatal OCD. Furthermore, current knowledge about these patients is still limited. The aim of this review article is the presentation of phenomenology, pathogenesis, differential diagnosis and treatment of perinatal OCD. The mental situation of the female patients can be improved and stabilised if early diagnosis of a perinatal OCD leads to early initiation of an adequate therapy. This will then enable a good and stable mother-child relationship to develop.

Literatur

• 1 Zaudig M. Epidemiologie, Komorbidität und Verlauf der Zwangsstörung. In: Zaudig M, Hauke W, Hegerl U, Hrsg Die Zwangsstörung, Diagnostik und Therapie. 2. Aufl. Stuttgart: Schattauer; 2002: 33-39
  Google Scholar
• 2 Ross L E, McLean L M. Anxiety disorders during pregnancy and the postpartum period: a systematik review.  J Clin Psychiatry. 2006;  67 1285-1298
  Google Scholar
• 3 Neziroglu F, Anemone R, Yaryura-Tobias J A. Onset of obsessive-compulsive disorder in pregnancy.  Am J Psychiatry. 1992;  149 947-950
  Google Scholar
• 4 Williams K E, Koran L M. Obsessive-compulsive disorder in pregnancy, the puerperium, and the premenstruum.  J Clin Psychiatry. 1997;  58 330-334
  Google Scholar
• 5 Abramowitz J S, Schwartz S A, Moore K M et al. Obsessive-compulsive symptoms in pregnancy and the puerperium: a review of the literature.  J Anxiety Disorders. 2003;  17 461-478
  Google Scholar
• 6 Kalra H, Tandon R, Trivedi J K et al. Pregnancy-induced obsessive compulsive disorder: a case report.  Annals of Generaly Psychiatry. 2005;  4 1-3
  Google Scholar
• 7 Uguz F, Gezginc K, Zeytinci I E et al. Obsessive-compulsive disorder in pregnant women during the third trimester of pregnancy.  Comprehensive Psychiatry. 2007;  48 441-445
  Google Scholar
• 8 Uguz F, Gezginc K, Kayhan F et al. Is pregnancy associated with mood and anxiety disorders? A cross-sectional study.  Gen Hosp Psychiatry. 2010;  32 213-215
  Google Scholar
• 9 Forray A, Fosseneanu M, Pittman B et al. Onset and exacerbation of obsessive-compulsive disorder in pregnancy and the postpartum period.  J Clin Psychiatry. 2010;  71 1061-1068
  Google Scholar
• 10 Sichel D A, Cohen L S, Dimmock J A et al. Postpartum obsessive compulsive disorder: a case series.  J Clin Psychiatry. 1993;  54 156-159
  Google Scholar
• 11 Arnold L M. A case series of women with postpartum-onset obsessive-compulsive disorder.  Prim Care Companion J Clin Psychiatry. 1999;  1 103-108
  Google Scholar
• 12 Labad J, Menchon J M, Alonso P et al. Female reproductive cycle and obsessive-compulsive disorder.  J Clin Psycchiatry. 2005;  66 428-435
  Google Scholar
• 13 Zambaldi C F, Cantilino A, Montenegro A C et al. Postpartum obsessive-compulsive disorder:prevalence and clinical characteristics.  Comprehensive Psychiatry. 2009;  50 503-509
  Google Scholar
• 14 Niedermeier N, Zaudig M. Definition und Beschreibung der Zwangsphänomene. In: Zaudig M, Hauke W, Hegerl U, Hrsg Die Zwangsstörung, Diagnostik und Therapie. 2. Aufl. Stuttgart: Schattauer; 2002: 1-11
  Google Scholar
• 15 Brockington I F, Macdonald E, Wainscott G. Anxiety, obsessions and morbid preoccupations in pregnancy and the puerperium.  Arch Womens Ment Health. 2006;  9 253-263
  Google Scholar
• 16 Martini J, Wittchen H U, Soares C N et al. New women-specific diagnostic modules: the Composition International Diagnostic Interview for Women (CIDI-VENUS).  Arch Womens Ment Health. 2009;  12 281-289
  Google Scholar
• 17 Austin M P. Classification of mental health disorders in the perinatal period: future directions for DSM-V and ICD-11.  Arch Womens Ment Health. 2010;  13 41-44
  Google Scholar
• 18 Mavrogiorgou P, Juckel G. Depressive Störungen im Rahmen des weiblichen Zyklus und der Schwangerschaft. In: Hegerl U, Hoff P, Hrsg. Depressionsbehandlung unter komplizierenden Bedingungen.. Bremen: Uni-Med; 2003: 76-88
  Google Scholar
• 19 Leung B M, Kaplan B J. Perinatal depression: prevalence, risks, and the nutrition link - a review of the literature.  J Am Diet Assoc. 2009;  109 1566-1575
  Google Scholar
• 20 Lancaster C A, Gold K J, Flynn H A et al. Risk factors for depressive symptoms during pregnancy: a systematic review.  Am J Obstet Gynecol. 2010;  202 5-14
  Google Scholar
• 21 Riecher-Rössler A. Psychische Störungen und Erkrankungen nach der Entbindung.  Fortschr Neurol Psychiat. 1997;  65 97-107
  Google Scholar
• 22 Watkins M E, Newport D J. Psychosis in pregnancy.  Obstet Gynecol. 2009;  113 1349-1353
  Google Scholar
• 23 Van Mullen C, Tillet J. Psychiatric disorders in pregnancy.  J Perinatal Neonatal Nurs. 2009;  23 124-130
  Google Scholar
• 24 Kendell R E, Chalmers J C, Platz C. Epidemiology of puerperal psychoses.  Brit J Psychiat. 1987;  150 662-673
  Google Scholar
• 25 Jones I, Heron J, Blackmore E R et al. Incidence of hospitalization for postpartum psychotic and bipolar episodes.  Arch Gen Psychiatry. 2008;  65 356
  Google Scholar
• 26 Spinelli M G. Postpartum psychosis: detection of risk and management.  Am J Psychiatry. 2009;  166 405-408
  Google Scholar
• 27 Sharma V, Khan M. Identification of bipolar disorder in women with postpartum depression.  Bipolar Disord. 2010;  12 335-340
  Google Scholar
• 28 Doucet S, Dennis C L, Letourneau N et al. Differentiation and clinical implications of postpartum depression and postpartum psychosis.  J Obstet Gynecol Neonatal Nurs. 2009;  38 269-279
  Google Scholar
• 29 Bergink V, Koorengevel K M. Postpartum depression with psychotic features.  Am J Psychiatry. 2010;  167 476-477
  Google Scholar
• 30 Wisner K, Moses-Kolko E L, Sit D KY. Postpartum depression: a disorder in search of a definition.  Arch Womens Ment Health. 2010;  13 37-40
  Google Scholar
• 31 Abramowitz J S, Meltzer-Brody S, Leserman J et al. Obsessional thoughts and compulsive behaviors in a sample of women with postpartum mood symptoms.  Arch Womens Ment Health. 2010;  DOI: 10.1007 /s00737-010-0172-4
  Google Scholar
• 32 Friedman S H, Resnick P J. Postpartum depression: an update.  Womens Health. 2009;  5 287-295
  Google Scholar
• 33 Sichel D A, Cohen L S, Rosenbaum J F et al. Postpartum onset of obsessive-compulsive disorder.  Psychosomatics. 1993;  34 277-279
  Google Scholar
• 34 Wisner K L, Peindl K S, Gigliotti T et al. Obsessions and compulsions in women with postpartum depression.  J Clin Psychiatry. 1999;  60 176-180
  Google Scholar
• 35 Wenzel A, Haugen E N, Jackson L C et al. Anxiety symptoms and disorders at eight weeks postpartum.  J Anxiety Disord. 2005;  19 295-311
  Google Scholar
• 36 Navarro P, Garcia-Esteve L, Ascaso C et al. Non-psychotic psychiatric disorders after childbirth: prevalence and comorbidity in a community sample.  J Affect Disord. 2008;  109 171-176
  Google Scholar
• 37 Voderholzer U. Obsessive-compulsive disorders.  Fortschr Neurol Psychiatr. 2005;  73 526-542
  Google Scholar
• 38 Zurowski B, Hohagen F, Kordon A. Neurobiologie der Zwangsstörung. Teil 1: Konzepte zur Pathophysiologie und Genetik.  Nervenheilkunde. 2009;  9 625-630
  Google Scholar
• 39 Zurowski B, Hohagen F, Kordon A. Neurobiologie der Zwangsstörung. Teil 2: Konzepte und Befunde aus der Neurobildgebung.  Nervenheilkunde. 2009;  11 809-816
  Google Scholar
• 40 Lasiuk G C, Hegadoren K M. The effects of estradiol on central serotonergic systems and its relationship to mood in women.  Biol Res Nurs. 2007;  9 147-160
  Google Scholar
• 41 Rybaczyk L A, Bashaw M J, Pathak D R et al. An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology.  BMC Womens Health. 2005;  20 5-12
  Google Scholar
• 42 Amin Z, Canli T, Epperson C N. Effect of estrogen-serotonin interactions on mood and cognition.  Behav Cogn Neurosci Rev. 2005;  4 43-58
  Google Scholar
• 43 Ladisich W. Influence of progesterone on serotonin metabolism: a possible causal factor for mood changes.  Psychoneuroendokrinology. 1977;  2 257-266
  Google Scholar
• 44 Le Melledo J M, Baker G. Role of progesterone and other neuroactive steroids in anxiety disorders.  Expert Rev Neurother. 2004;  4 851-860
  Google Scholar
• 45 Den Boer J A, Westenberg H G. Oxytocin in obsessive-compulsive disorder.  Peptides. 1992;  13 1083-1085
  Google Scholar
• 46 Leckman J F, Goodman W K, North W G et al. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette`s syndrome and healthy controls.  Arch Gen Psychiatry. 1994;  51 82-92
  Google Scholar
• 47 Marazziti D, Catena Dellòsso M. The role of oxytocin in neuropsychiatric disorders.  Curr Med Chem. 2008;  15 698-704
  Google Scholar
• 48 Altemus M, Jacobson K R, Debellis M et al. Normal CSF oxytocin and NPY levels in OCD.  Biol Psychiatry. 1999;  45 931-933
  Google Scholar
• 49 Epperson C N, McDougle C J, Price L H. Intranasal oxytocin in obsessive-compulsive disorder.  Biol Psychiatry. 1996;  40 547-549
  Google Scholar
• 50 Altemus M, Pigott T, Kalogeras K T et al. Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder.  Arch Gen Psychiatry. 1992;  49 9-20
  Google Scholar
• 51 Kluge M, Schüssler P, Künzel H E et al. Increased nocturnal secretion of ACTH and cortisol in obsessive-compulsive disorder.  J Psychiatry Res. 2007;  41 928-933
  Google Scholar
• 52 Gustafsson P E, Gustafsson P A, Ivarsson T et al. Diurnal cortisol levels and cortisolresponse in youths with obsessive-compulsive disorder.  Neuropsychobiology. 2007;  57 14-21
  Google Scholar
• 53 Brunton P J, Russel J A. The expectant brain: adapting for motherhood.  Nature Rev Neuroscience. 2008;  9 11-25
  Google Scholar
• 54 Vasconcelos M S, Sampaio A S, Hounie A G et al. Prenatal, Perinatal, and postnatal risk factors in obsessive-compulsive disorder.  Biol Psychiatry. 2007;  61 301-307
  Google Scholar
• 55 Leckman J F, Mayes L C, Feldman R et al. Early parental preoccupations and behaviors and their possible relationship to the symptoms of obsessive-compulsive disorder.  Acta Psychiatr Scand Suppl. 1999;  398 1-26
  Google Scholar
• 56 Fairbrother N, Abramowitz J S. New parenthood as a risk factor for the development of obsessional problems.  Beh Res Ther. 2007;  45 2155-2163
  Google Scholar
• 57 Mowrer O H. On the dual nature of learning-a re-interpretation of „conditioning and „problem solving”.  Harvard Educational Review. 1947;  17 102-148
  Google Scholar
• 58 Niedemeier N, Bossert-Zaudig S. Psychologische Modelle zur Erklärung der Entstehung und Aufrechterhaltung von Zwangsstörungen. In: Zaudig M, Hauke W, Hegerl U, Hrsg. Die Zwangsstörung, Diagnostik und Therapie. 2. Aufl. Stuttgart: Schattauer; 2002: 65-72
  Google Scholar
• 59 Salkovskis P, Forrester E, Richards C. Cognitive-behavioral approach to understanding obsessional thinking.  Br J Psychiatry. 1998;  35 53-63
  Google Scholar
• 60 Varkukla M, Viguera A C, Gonsalves L. Depression and pregnancy.  Compr Ther. 2009;  35 44-49
  Google Scholar
• 61 Hegerl U, Mavrogiorgou P. Biologische Grundlagen von Zwangsstörungen. In: Zaudig M, Hauke W, Hegerl U, Hrsg Die Zwangsstörung, Diagnostik und Therapie. 2. Aufl Stuttgart: Schattauer; 2002: 43-63
  Google Scholar
• 62 Brüne M. The evolutionary psychology of obsessive-compulsive disorder. The role of cognitive metarepresentation.  Perspectives in Biology and Medicine. 2006;  49 317-329
  Google Scholar
• 63 Mataix-Cols D, do Rosario-Campos M C, Leckman J F. A multidimensional model of obsessive-compulsive disorder.  Am J Psychiatry. 2005;  162 228-238
  Google Scholar
• 64 Leckman J F. An evolutionary and developmental perspective.  Biol Psychiatry. 2007;  62 831-832
  Google Scholar
• 65 Saad G. sex differences in OCD symptomatology: an evolutionary perspective.  Medical Hypotheses. 2006;  67 1455-1459
  Google Scholar
• 66 Brandes M, Soares C N, Cohen L S. Postpartum onset obsessive-compulsive disorder: diagnosis and management.  Arch Womens Ment Health. 2004;  7 99-110
  Google Scholar
• 67 Misri S, Milis L. Obsessive-compulsive disorder in the postpartum: open-label trial of quetiapine augmentation.  J Clin Psychopharmacol. 2004;  24 624-627
  Google Scholar
• 68 Marazziti D, Consoli G. Treatment strategies for obsessive-compulsive disorder.  Exp Opin Pharmacother. 2010;  11 331-343
  Google Scholar
• 69 Tschudin S, Lapaire O. Antidepressiva in der Schwangerschaft.  Therapeutische Umschau. 2005;  62 17-22
  Google Scholar
• 70 Källen B A, Olausson P O. Maternal use of selective reuptake inhibitors in early pregnancy and infant congenital malformations.  Birth Defects Res A Clin Mol Teratol. 2007;  79 301-308
  Google Scholar
• 71 Alwan S, Friedman J M. Safety of selective serotonin reuptake inhibitors in pregnancy.  CNS Drugs. 2009;  23 493-509
  Google Scholar
• 72 Tuccori M, Testi A, Antonioli L et al. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.  Clin Ther. 2009;  31 1426-1453
  Google Scholar
• 73 Toh S, Mitchell A A, Loik C et al. Antidepressant use during pregnancy and the risk of preterm delivery and fetal growth restriction.  J Clin Psychopharmacol. 2009;  29 555-560
  Google Scholar
• 74 Källen B, Olausson P O. Maternal use of selective serotonin reuptake inhibitors and persistent pulmonary hypertension of the newborn.  Pharmacoepidemiol Drug Saf. 2008;  17 801-806
  Google Scholar
• 75 Warburton W, Hertzman C, Oberlander T F. A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health.  Acta Psychiatr Scand. 2010;  121 471-479
  Google Scholar
• 76 Nulman I, Rovet J, Stewart D E et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study.  Am J Psychiatry. 2002;  159 1889-1895
  Google Scholar
• 77 Iqbal M M, Sobhan T, Aftab S R et al. Diazepam use during pregnancy: A review of the literature.  Del Med Jrl. 2002;  74 127-134
  Google Scholar
• 78 Freeman M P. Breastfeeding and antidepressants: Clinical dilemmas and expert perspectives.  J Clinic Psychiatry. 2009;  70 291-292
  Google Scholar

Dr. Paraskevi Mavrogiorgou

Klinik für Psychiatrie, Psychotherapie und Präventivmedizin, LWL-Universitätsklinikum

Alexandrinenstr.1

44791 Bochum

Email: paraskevi.mavrogiorgou-juckel@wkp-lwl.org